Luspatercept for transfusion-dependent ß-thalassemia: time to get real.

Musallam, Khaled M; Sheth, Sujit; Cappellini, Maria Domenica; Kattamis, Antonis; Kuo, Kevin H M; Taher, Ali T

Musallam, Khaled M; Sheth, Sujit; Cappellini, Maria Domenica; Kattamis, Antonis; Kuo, Kevin H M; Taher, Ali T.

Afiliación

Musallam KM; Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Sheth S; Division of Hematology and Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
Cappellini MD; Department of Clinical Sciences and Community, University of Milan, Ca' Granda Foundation IRCCS Maggiore Policlinico Hospital, Milan, Italy.
Kattamis A; First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
Kuo KHM; Division of Hematology, University of Toronto, Toronto, ON, Canada.
Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Beirut, 11072020 - Lebanon.

Ther Adv Hematol ; 14: 20406207231195594, 2023.

Article en En | MEDLINE | ID: mdl-37645382

Palabras clave

anemia; ineffective erythropoiesis; novel therapy; thalassemia; transfusion

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Hematol Año: 2023 Tipo del documento: Article País de afiliación: Emiratos Árabes Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google